Women's acceptance of an injectable progestin-only contraceptive in a free-choice environment in Turkey.
A progestin-only injectable contraceptive has been integrated into the method mix at a well-woman clinic in Turkey. During the period from 1st December 1996 to 1st December 1997, among 3545 new method acceptors at the clinic, 254 women decided to use the injectable, giving an initial acceptance rate of 7%. Continuation rates, however, were quite low: 43.7% at 6 months and only 18.5% at 12 months. Though all the side-effects were mentioned during the counselling sessions, side-effects such as amenorrhea and spotting might have been underestimated by the potential users of this method, which was new in the country. A more detailed counselling with a strong emphasis on frequent side-effects might lower the initial acceptance rate, but can help to increase the continuation rates.
Say
L
L
Woman and Child Health Training and Research Unit, Cocuk Sağliği Enstitüsü, Capa, Istanbul, Turkey.
Ortayli
N
N
Nalbant
H
H
D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003657:Decision Making; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D017060:Patient Satisfaction; D045167:Progesterone Congeners / Q000008:administration & dosage*; D012189:Retrospective Studies; D014421:Turkey; D016387:Women's Health
D003271:Contraceptive Agents, Female; D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate